Filing Details
- Accession Number:
- 0000919574-17-005533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-20 18:07:01
- Reporting Period:
- 2017-07-20
- Filing Date:
- 2017-07-20
- Accepted Time:
- 2017-07-20 18:07:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1479419 | Kala Pharmaceuticals Inc. | KALA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325713 | Bruce Kovner | C/O Caxton Corporation 731 Alexander Road, Building #2 Princeton NJ 08540 | No | No | Yes | No | |
1388551 | Caxton Corp | 731 Alexander Road Building #2 Princeton NJ 08540 | No | No | Yes | No | |
1576081 | Cdk Associates, L.l.c. | C/O Caxton Corporation 731 Alexander Road, Building #2 Princeton NJ 08540 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-20 | 215,000 | $15.00 | 215,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.